secwatch.observer — SEC 8-K summary
======================================

Issuer:     Z Squared Inc. (ZSQR)
CIK:        0001759186
Form:       8-K
Filed at:   2023-01-31T23:59:59+00:00
Accession:  0001683168-23-000454
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Coeptis enters sponsored research agreement with Univ. of Pittsburgh for SNAP-CAR HER2 pre-clinical work
--------------------------------------------------------------------------------

- Sponsored research agreement with University of Pittsburgh to advance SNAP-CAR T cells targeting HER2-positive cancers.
- Pre-clinical work will support IND filing for clinical trials, initially targeting ovarian cancer.
- Research led by Dr. Lohmueller and Dr. Deiters; IQVIA to assist as CRO for lead candidate selection.
- HER2 overexpressed in ~28% of ovarian cancer and ~25% of breast cancer cases, per the press release.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1759186/000168316823000454/0001683168-23-000454-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1759186/000168316823000454/coeptis_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-23-000454

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer